Peter N. Kellogg

Peter N. Kellogg discloses dealings in 2 companies, chiefly Alnylam Pharmaceuticals, Inc. and Celgene Corp /DE/. We count 4 filings; the first trade dates from 12 February 2016 and the latest from 20 May 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 22 May 2026, the filings show a share grant in Alnylam Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.